Kai Kentaro, Kawano Yasushi, Yano Mitsutake, Okamoto Mamiko, Hori Eiichi, Nasu Kaei, Narahara Hisashi
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan; Department of Obstetrics and Gynecology, Nakatsu Municipal Hospital, Oita, Japan.
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan.
Taiwan J Obstet Gynecol. 2018 Apr;57(2):315-318. doi: 10.1016/j.tjog.2018.02.024.
Although uterine didelphys per se is not associated with an impaired ability to conceive, the association between uterine anomalies and gestational trophoblastic neoplasia (GTN) remains unclear. The management of chemotherapy-resistant GTN in women with uterine didelphys raises a new issue regarding whether to perform a hemi-hysterectomy.
A 23-year-old, gravida 1, para 0 Japanese woman was referred with a failed intermittent cervical dilatation for hematometra. Four years previously, she developed a GTN Stage III, score 5. As two cycles of chemotherapy with methotrexate (MTX) and one cycle of EMA-CO (etoposide, MTX, actinomycin D, cyclophosphamide and vincristine) did not result in remission, we performed an abdominal hemi-hysterectomy. After a canalization procedure and cervicoplasty were performed, the patient conceived naturally and prematurely delivered by cesarean section twice.
A hemi-hysterectomy should be considered for fertility preservation when GTN develops on either side of a didelphic uterus and adjuvant chemotherapy does not result in remission.
虽然双子宫本身与受孕能力受损无关,但子宫异常与妊娠滋养细胞肿瘤(GTN)之间的关联仍不明确。双子宫女性化疗耐药性GTN的管理引发了一个关于是否进行半子宫切除术的新问题。
一名23岁、孕1产0的日本女性因子宫积血间歇性宫颈扩张失败前来就诊。四年前,她被诊断为GTNⅢ期,评分为5分。由于两周期甲氨蝶呤(MTX)化疗和一周期EMA-CO(依托泊苷、MTX、放线菌素D、环磷酰胺和长春新碱)化疗均未缓解,我们进行了腹部半子宫切除术。在进行了疏通手术和宫颈成形术后,患者自然受孕并两次剖宫产早产。
当双子宫一侧发生GTN且辅助化疗未缓解时,为保留生育能力应考虑行半子宫切除术。